Glenmark Pharmaceuticals has recalled more than 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets
19:58, 10 Dec 2025Updated 21:10, 10 Dec 2025
Blood pressure medication has been recalled(Image: Getty Images)
A widely used blood pressure medication has been recalled over fears that it may be contaminated with another drug.
More than 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets, marketed under the brand name Ziac, have been recalled by Glenmark Pharmaceuticals Inc in the US. The tablets may have been cross-contaminated with other products, according to a recall notice published by the Food and Drug Administration.
The tablets are understood to be commonly used to treat high blood pressure, also known as hypertension, by blocking beta-1 receptors in the heart, allowing it to come to a regular beat, according to WebMD.
The recall notice says that testing of samples “showed presence of ezetimibe,” which is a drug used to treat high cholesterol. The December 1 recall was listed as Class III, meaning the use or exposure to the product is “not likely to cause adverse health consequences,” the FDA said.
The affected pills come in 2.5mg and 6.25mg doses, according to the agency. Specific packages impacted include 30-count bottles NDC-68462-878-30, 100-count bottles NDC-68462-878-01 and 500-count bottles NDC-68462-878-05, according to the recall.
The affected lot numbers have expiration dates spanning from November 2025 to May 2026. A total of 11,136 bottles were impacted in the recall. The FDA has not yet said what patients should do if their medication is affected by the recall.